Featured
-
AUA 2020 Virtual Experience Coverage
Check out our coverage of the AUA 2020 virtual experience, focusing on the hot topics in urology. -
Impact of Nutrition on Urologic and Renal Diseases
By watching what they eat and drink, patients can control such common problems as overactive bladder, prostatitis, interstitial cystitis, and chronic kidney disease. -
ADT May Decrease Risk of COVID-19 in Men With Prostate Cancer, Study Finds
TMPRSS2, a serine protease expressed in prostate and lung tissue that is necessary for SARS-CoV-2 viral infectivity of host cells, is activated by the androgen receptor. -
Nearly 40% of This Nephrologist’s ESKD Patients Dialyze at Home
Shaminder Gupta, MD, is a nephrologist who practices in Houma, Louisiana. He serves as the section chief at his hospital and also as Corporate Medical Director at Monogram Health, a renal disease care management company. He tells Renal & Urology News how he developed and manages a home dialysis program in which approximately 40% of his patients… -
Olaparib Approved for Metastatic Castration-Resistant Prostate Cancer
The FDA has approved Lynparza® (olaparib; AstraZeneca and Merck) for the treatment of adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with enzalutamide or abiraterone. -
SABR Found to Improve Outcomes in Recurrent Oligometastatic HSPC
In patients with recurrent oligometastatic hormone-sensitive prostate cancer, stereotactic ablative radiation therapy decreased the risk of disease progression compared with observation alone, a phase 2 study found. -
COVID-19 and Acute Kidney Injury: Challenges and Management
Acute kidney injury may develop in up to 30% of COVID-19 patients in intensive care units, according to a nephrologist at Emory University School of Medicine in Atlanta. -
Apologies, Properly Made, Go Far in Maintaining Doctor-Patient Relationships
From an ethical perspective, disclosing adverse events to patients is predicated on the idea that physicians have obligations to tell the truth, but physicians may worry that apologizing will incur greater responsibility for liability. -
Virtual Care Beyond the Pandemic
Telemedicine can assist in many aspects of care.
Latest Nephrology News
Voclosporin NDA for Lupus Nephritis Submitted to FDA
Considerations for Hydroxychloroquine Use in Patients With Diabetes
Co-Dispensing of Benzodiazepines and Opioids Dangerous in HD
Latest Urology News
Treatment With Hydroxychloroquine-Azithromycin, Progressive Cancer Found to Increase Risk of Death for Patients With COVID-19
Metastatic RCC Subtypes Differ in Sites of Metastases
Tivozanib Offers Survival Benefit Similar to Sorafenib in Refractory mRCC
Departments
Latest Digital Issue
-
Loading...
-
Loading...
